Ruben, Eglesiria D.
HRN: 22-07-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/22/2022
10/29/2022
PO
500,000 Units
TID
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes